Literature DB >> 21528252

Differential expression of vacuolar-type H+-ATPase between normal human pancreatic islet B-cells and insulinoma cells.

T Ohta1, M Yamamoto, M Numata, S Iseki, H Kitagawa, M Kayahara, T Nagakawa, K Miwa, A Nakagawa, T Morise, S Ohkuma, T Terada.   

Abstract

Recent studies have shown that bafilomycin A(1)-sensitive vacuolar type H+-ATPase (V-ATPase) is responsible for the acidification of intracellular compartments in eukaryotic cells. B-cells of pancreatic islets also are known to include acidifying secretory vesicles which are the major cellular site of proinsulin to insulin conversion. This study was designed to examine immunohistochemically the level of V-ATPase protein expression in normal pancreas (five cases) and benign insulinoma (six cases), using mouse monoclonal antibody raised against the 116 kDa subunit of human V-ATPase. Light microscopic immunohistochemistry revealed that moderate to marked V-ATPase expression was observed in normal islet B-cells, while insulinoma cells in each case expressed V-ATPase faintly or not at all. By immunoelectron microscopy, the majority of secretory vesicles in insulinoma cells did not express V-ATPase protein at their endomembranes, although mild to marked V-ATPase expression was noted at the endomembrane of secretory vesicles in normal islet B-cells. Thus, differential expression of V-ATPase protein at the endomembrane of secretory vesicles was observed between normal islet B-cells and insulinoma cells. These findings suggest that the reduced activity of V-ATPase per insulin secretory vesicle in insulinoma cells have a profound effect on the efficiency of proteolytic cleavage of proinsulin.

Entities:  

Year:  1997        PMID: 21528252     DOI: 10.3892/ijo.11.3.597

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Vesicular nucleotide transporter-mediated ATP release regulates insulin secretion.

Authors:  Jessica C Geisler; Kathryn L Corbin; Qin Li; Andrew P Feranchak; Craig S Nunemaker; Chien Li
Journal:  Endocrinology       Date:  2012-12-19       Impact factor: 4.736

2.  Genetic basis for the increased expression of vacuolar H+ translocating ATPase genes upon imatinib treatment in human lymphoblastoid cells.

Authors:  Hemant Kulkarni; Harald H H Göring; Joanne E Curran; Vincent Diego; Thomas D Dyer; Shelley Cole; Ken R Walder; Greg R Collier; John Blangero; Melanie A Carless
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-19       Impact factor: 3.333

Review 3.  V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.

Authors:  Xiaohong Duan; Shaoqing Yang; Lei Zhang; Tielin Yang
Journal:  Theranostics       Date:  2018-10-26       Impact factor: 11.556

Review 4.  Iron Metabolism in Pancreatic Beta-Cell Function and Dysfunction.

Authors:  Algerta Marku; Alessandra Galli; Paola Marciani; Nevia Dule; Carla Perego; Michela Castagna
Journal:  Cells       Date:  2021-10-22       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.